Literature DB >> 17610279

Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla.

Stefan Posse1, Ricardo Otazo, Arvind Caprihan, Juan Bustillo, Hongji Chen, Pierre-Gilles Henry, Malgorzata Marjanska, Charles Gasparovic, Chun Zuo, Vincent Magnotta, Bryon Mueller, Paul Mullins, Perry Renshaw, Kamil Ugurbil, Kelvin O Lim, Jeffry R Alger.   

Abstract

In this multicenter study, 2D spatial mapping of J-coupled resonances at 3T and 4T was performed using short-TE (15 ms) proton echo-planar spectroscopic imaging (PEPSI). Water-suppressed (WS) data were acquired in 8.5 min with 1-cm(3) spatial resolution from a supraventricular axial slice. Optimized outer volume suppression (OVS) enabled mapping in close proximity to peripheral scalp regions. Constrained spectral fitting in reference to a non-WS (NWS) scan was performed with LCModel using correction for relaxation attenuation and partial-volume effects. The concentrations of total choline (tCho), creatine + phosphocreatine (Cr+PCr), glutamate (Glu), glutamate + glutamine (Glu+Gln), myo-inositol (Ins), NAA, NAA+NAAG, and two macromolecular resonances at 0.9 and 2.0 ppm were mapped with mean Cramer-Rao lower bounds (CRLBs) between 6% and 18% and approximately 150-cm(3) sensitive volumes. Aspartate, GABA, glutamine (Gln), glutathione (GSH), phosphoethanolamine (PE), and macromolecules (MMs) at 1.2 ppm were also mapped, although with larger mean CRLBs between 30% and 44%. The CRLBs at 4T were 19% lower on average as compared to 3T, consistent with a higher signal-to-noise ratio (SNR) and increased spectral resolution. Metabolite concentrations were in the ranges reported in previous studies. Glu concentration was significantly higher in gray matter (GM) compared to white matter (WM), as anticipated. The short acquisition time makes this methodology suitable for clinical studies.

Entities:  

Mesh:

Year:  2007        PMID: 17610279     DOI: 10.1002/mrm.21287

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  66 in total

Review 1.  Imaging based magnetic resonance spectroscopy (MRS) localization for quantitative neurochemical analysis and cerebral metabolism studies.

Authors:  Phil Lee; Peter Adany; In-Young Choi
Journal:  Anal Biochem       Date:  2017-01-10       Impact factor: 3.365

2.  Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.

Authors:  Joseph O'Neill; John Piacentini; Susanna Chang; Ronald Ly; Tsz M Lai; Casey C Armstrong; Lindsey Bergman; Michelle Rozenman; Tara Peris; Allison Vreeland; Ross Mudgway; Jennifer G Levitt; Noriko Salamon; Stefan Posse; Gerhard S Hellemann; Jeffry R Alger; James T McCracken; Erika L Nurmi
Journal:  Neuropsychopharmacology       Date:  2017-04-04       Impact factor: 7.853

3.  Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.

Authors:  Juan R Bustillo; Hongji Chen; Charles Gasparovic; Paul Mullins; Arvind Caprihan; Clifford Qualls; William Apfeldorf; John Lauriello; Stefan Posse
Journal:  Biol Psychiatry       Date:  2010-10-20       Impact factor: 13.382

Review 4.  Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.

Authors:  Stephen R Dager; Neva M Corrigan; Todd L Richards; Stefan Posse
Journal:  Top Magn Reson Imaging       Date:  2008-04

Review 5.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

6.  Regional distributions of brain glutamate and glutamine in normal subjects.

Authors:  Mohammed Z Goryawala; Sulaiman Sheriff; Andrew A Maudsley
Journal:  NMR Biomed       Date:  2016-06-28       Impact factor: 4.044

7.  Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury.

Authors:  Andrea S Kierans; Ivan I Kirov; Oded Gonen; Gillian Haemer; Eric Nisenbaum; James S Babb; Robert I Grossman; Yvonne W Lui
Journal:  Neurology       Date:  2014-01-08       Impact factor: 9.910

8.  3D high-resolution imaging of 2-hydroxyglutarate in glioma patients using DRAG-EPSI at 3T in vivo.

Authors:  Zhongxu An; Vivek Tiwari; Jeannie Baxter; Michael Levy; Kimmo J Hatanpaa; Edward Pan; Elizabeth A Maher; Toral R Patel; Bruce E Mickey; Changho Choi
Journal:  Magn Reson Med       Date:  2018-09-14       Impact factor: 4.668

9.  Pharmacological stress impairs working memory performance and attenuates dorsolateral prefrontal cortex glutamate modulation.

Authors:  Eric A Woodcock; Mark K Greenwald; Dalal Khatib; Vaibhav A Diwadkar; Jeffrey A Stanley
Journal:  Neuroimage       Date:  2018-11-17       Impact factor: 6.556

10.  Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients.

Authors:  William E Wu; Ivan I Kirov; Assaf Tal; James S Babb; Sarah Milla; Joseph Oved; Howard L Weiner; Orrin Devinsky; Oded Gonen
Journal:  Epilepsy Behav       Date:  2013-03-22       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.